Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Knee Implant Material Cleared by FDA

By HospiMedica staff writers
Posted on 16 Nov 2000
A new kind of polyethylene with improved resistance to wear, called Durasul, has been cleared by the U.S. More...
Food and Drug Administration (FDA) for use in the Natural-Knee implants marketed by Sulzer Medica (Winterthur, Switzerland). A knee implant with Durasul could last longer than conventional knee implants. Sulzer is the first company to market the new technology for knee replacement.

Durasul was developed as a joint project between the Massachusetts Institute of Technology, the Orthopedic Biomechanics and Biomaterials research laboratory at the Massachusetts General Hospital (both in Boston, USA) and Sulzer Orthopedics. In extensive laboratory testing, Durasul has been shown to be more wear-resistant than the polyethylene commonly used in knee implants.

Over time, the continuous movement between the metal and plastic can cause the polyethylene in knee implants to crack, pit, and delaminate. This may cause microscopic particles to break off and be attacked by the body's immune system, leading to osteolysis, a loss of bone tissue that can lead to implant failure. Durasul was designed to solve the problems of delamination and wear. Previously, Durasul was cleared by the FDA for us in hip implants.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.